276 related articles for article (PubMed ID: 28961381)
21. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
[TBL] [Abstract][Full Text] [Related]
22. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study.
Mazzini L; Mareschi K; Ferrero I; Miglioretti M; Stecco A; Servo S; Carriero A; Monaco F; Fagioli F
Cytotherapy; 2012 Jan; 14(1):56-60. PubMed ID: 21954839
[TBL] [Abstract][Full Text] [Related]
23. Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study.
Bonab MM; Sahraian MA; Aghsaie A; Karvigh SA; Hosseinian SM; Nikbin B; Lotfi J; Khorramnia S; Motamed MR; Togha M; Harirchian MH; Moghadam NB; Alikhani K; Yadegari S; Jafarian S; Gheini MR
Curr Stem Cell Res Ther; 2012 Nov; 7(6):407-14. PubMed ID: 23061813
[TBL] [Abstract][Full Text] [Related]
24. Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study.
Jamali F; Aldughmi M; Atiani S; Al-Radaideh A; Dahbour S; Alhattab D; Khwaireh H; Arafat S; Jaghbeer JA; Rahmeh R; Abu Moshref K; Bawaneh H; Hassuneh MR; Hourani B; Ababneh O; Alghwiri A; Awidi A
Cell Transplant; 2024; 33():9636897241233045. PubMed ID: 38450623
[TBL] [Abstract][Full Text] [Related]
25. Safety and Clinical Effects of Mesenchymal Stem Cells Secreting Neurotrophic Factor Transplantation in Patients With Amyotrophic Lateral Sclerosis: Results of Phase 1/2 and 2a Clinical Trials.
Petrou P; Gothelf Y; Argov Z; Gotkine M; Levy YS; Kassis I; Vaknin-Dembinsky A; Ben-Hur T; Offen D; Abramsky O; Melamed E; Karussis D
JAMA Neurol; 2016 Mar; 73(3):337-44. PubMed ID: 26751635
[TBL] [Abstract][Full Text] [Related]
26. Intravenous transplantation of bone marrow-derived mesenchymal stromal cells in patients with multiple sclerosis, a phase I/IIa, double blind, randomized controlled study.
Nabavi SM; Karimi S; Arab L; Aghdami N; Joghtaei N; Maroufizadeh S; Jarooghi N; Bolurieh T; Abbasi F; Mardpour S; Azimyian V; Moeininia F; Sanjari L; Hosseini SE; Vosough M
Mult Scler Relat Disord; 2023 Oct; 78():104895. PubMed ID: 37515913
[TBL] [Abstract][Full Text] [Related]
27. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis.
Oh KW; Moon C; Kim HY; Oh SI; Park J; Lee JH; Chang IY; Kim KS; Kim SH
Stem Cells Transl Med; 2015 Jun; 4(6):590-7. PubMed ID: 25934946
[TBL] [Abstract][Full Text] [Related]
28. Growing evidence supporting the use of mesenchymal stem cell therapies in multiple sclerosis: A systematic review.
Oliveira AG; Gonçalves M; Ferreira H; M Neves N
Mult Scler Relat Disord; 2020 Feb; 38():101860. PubMed ID: 31765999
[TBL] [Abstract][Full Text] [Related]
29. Transplantation of Mesenchymal Stromal Cells in Patients With Amyotrophic Lateral Sclerosis: Results of Phase I/IIa Clinical Trial.
Syková E; Rychmach P; Drahorádová I; Konrádová Š; Růžičková K; Voříšek I; Forostyak S; Homola A; Bojar M
Cell Transplant; 2017 Apr; 26(4):647-658. PubMed ID: 27938483
[TBL] [Abstract][Full Text] [Related]
30. Multiple transplantation of mesenchymal stem cells in a patient with active progressive multiple sclerosis: Long term therapeutic outcomes.
Liu S; Mao X; Hou Z; Wei H; Gao H; Liu Y; Xie Y; Tang W; He S; Zhao Y; Wang W; Li L; Wang X; Meng M
Clin Neurol Neurosurg; 2022 Dec; 223():107475. PubMed ID: 36274549
[TBL] [Abstract][Full Text] [Related]
31. Safety and neurological assessments after autologous transplantation of bone marrow mesenchymal stem cells in subjects with chronic spinal cord injury.
Mendonça MV; Larocca TF; de Freitas Souza BS; Villarreal CF; Silva LF; Matos AC; Novaes MA; Bahia CM; de Oliveira Melo Martinez AC; Kaneto CM; Furtado SB; Sampaio GP; Soares MB; dos Santos RR
Stem Cell Res Ther; 2014 Nov; 5(6):126. PubMed ID: 25406723
[TBL] [Abstract][Full Text] [Related]
32. Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.
Rice CM; Marks DI; Ben-Shlomo Y; Evangelou N; Morgan PS; Metcalfe C; Walsh P; Kane NM; Guttridge MG; Miflin G; Blackmore S; Sarkar P; Redondo J; Owen D; Cottrell DA; Wilkins A; Scolding NJ
Trials; 2015 Oct; 16():463. PubMed ID: 26467901
[TBL] [Abstract][Full Text] [Related]
33. The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury.
Chudickova M; Vackova I; Machova Urdzikova L; Jancova P; Kekulova K; Rehorova M; Turnovcova K; Jendelova P; Kubinova S
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31547264
[TBL] [Abstract][Full Text] [Related]
34. Intra-discal injection of autologous, hypoxic cultured bone marrow-derived mesenchymal stem cells in five patients with chronic lower back pain: a long-term safety and feasibility study.
Elabd C; Centeno CJ; Schultz JR; Lutz G; Ichim T; Silva FJ
J Transl Med; 2016 Sep; 14(1):253. PubMed ID: 27585696
[TBL] [Abstract][Full Text] [Related]
35. Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.
Matas J; Orrego M; Amenabar D; Infante C; Tapia-Limonchi R; Cadiz MI; Alcayaga-Miranda F; González PL; Muse E; Khoury M; Figueroa FE; Espinoza F
Stem Cells Transl Med; 2019 Mar; 8(3):215-224. PubMed ID: 30592390
[TBL] [Abstract][Full Text] [Related]
36. Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study.
Pal R; Venkataramana NK; Bansal A; Balaraju S; Jan M; Chandra R; Dixit A; Rauthan A; Murgod U; Totey S
Cytotherapy; 2009; 11(7):897-911. PubMed ID: 19903102
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic Use of Intrathecal Mesenchymal Stem Cells in patients with Multiple Sclerosis: A Pilot Study with Booster Injection.
Sahraian MA; Mohyeddin Bonab M; Baghbanian SM; Owji M; Naser Moghadasi A
Immunol Invest; 2019 Feb; 48(2):160-168. PubMed ID: 30156938
[TBL] [Abstract][Full Text] [Related]
38. Image-guided percutaneous intralesional administration of mesenchymal stromal cells in subjects with chronic complete spinal cord injury: a pilot study.
Larocca TF; Macêdo CT; Souza BSF; Andrade-Souza YM; Villarreal CF; Matos AC; Silva DN; da Silva KN; de Souza CLEM; Paixão DDS; Bezerra MDR; Alves RL; Soares MBP; Dos Santos RR
Cytotherapy; 2017 Oct; 19(10):1189-1196. PubMed ID: 28760352
[TBL] [Abstract][Full Text] [Related]
39. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease.
Ciccocioppo R; Bernardo ME; Sgarella A; Maccario R; Avanzini MA; Ubezio C; Minelli A; Alvisi C; Vanoli A; Calliada F; Dionigi P; Perotti C; Locatelli F; Corazza GR
Gut; 2011 Jun; 60(6):788-98. PubMed ID: 21257987
[TBL] [Abstract][Full Text] [Related]
40. Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis.
Barreiro-González A; Sanz MT; Carratalà-Boscà S; Pérez-Miralles F; Alcalá C; Carreres-Polo J; España-Gregori E; Casanova B
Eur Neurol; 2022; 85(2):112-121. PubMed ID: 34788755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
